Small Cap Annovis Bio Inc. (NYSE: ANVS) stock is trading higher on Monday, with a session volume of 12.29 million compared to the average volume of 615.12 thousand as per data from Benzinga Pro. A ...

Disclosure: Our goal is to feature products and services that we think you'll find interesting and useful. If you purchase them, Entrepreneur may get a small share of the revenue from the sale from ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Cabaletta Bio ( (CABA)) has issued an ...

The original design manufacturing giant Flex Ltd. says it wants to help data center operators scale their operations more efficiently with what is effectively a new blueprint for gigawatt data centers ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The Burlington-based lab giant ...

“High quality, large-scale, fit-for-purpose datasets” continues to be the tagline for artificial intelligence (AI) models aiming to achieve scalable drug discovery to novel targets. While troves of ...

A California-startup focused on genetically editing human embryos — a step toward creating so-called designer babies — is raising money as many of Silicon Valley’s ultra-rich turn their attention to ...

Living 150 years could not just be possible – it could soon be inevitable, according to human biologist and biohacker Gary Brecka. "If you're alive in five years, I believe it will be your choice ...

A priceless treasure trove of biodata gathered from generations of Americans by Harvard University researchers may soon be lost due to additional funding cuts by the Trump administration, a leading ...

Other pharmaceutical and health care companies recently announced layoffs — including Bayer, Siemens, RWJBarnabas Health and Bristol Myers Squibb — as they struggled to integrate AI On March 11, ...

Nearly a year after Labcorp struck a deal for certain diagnostics assets from BioReference Health, the lab-testing giant is back to buy the firm’s cancer tests. Labcorp is paying $192.5 million for ...